Description
Lumiradx™ Sars-Cov-2 Ag Antigen Detection Respiratory Test Kit, Sold As 1/Each Lumiradx L016000109048
- Results In 12 Minutes
- Results Are For The Identification Of Sars-Cov-2 Nucleocapsid Protein Antigen; Antigen Is Generally Detectable In Nasal Swab Specimens During The Acute Phase Of Infection.
- The Lumiradx Sars-Cov-2 Ag Test Does Not Differentiate Between Sars-Cov And Sars-Cov-2.
- Rapid Microfluidic Immunofluorescence Assay Test Method
- Lumiradx Sars-Cov-2 Ag Test Is For Use Under An Emergency Use Authorization Only.
- Testing Is Limited To Laboratories Certified Under The Clinical Laboratory Improvement Amendments Of 1988 (Clia), 42 U.S.C 263A, That Meet The Requirements To Perform Moderate, High Or Waived Complexity Tests.
- Test Is Authorized For Use At The Point Of Care (Poc), I.E., In Patient Care Settings Operating Under A Clia Certificate Of Waiver, Certificate Of Compliance, Or Certificate Of Accreditation.
- Lumiradx Sars-Cov-2 Ag Test Is Intended For Use By Trained Clinical Laboratory Personnel And Individuals Trained In Point Of Care Settings, And Proficient In Performing Tests Using The Lumiradx Instrument.
- 48 Tests
Reagent, Sars-Cov-2 Antigen Test Strip Kit (48Test/Ea)
Respiratory Test Kit Lumiradx™ Sars-Cov-2 Ag 48 Tests Clia Waived
Lumiradx™
Sku: Mck-1197690_Ea
Mfgr Sku: L016000109048
1197690_Ea
Ships In 2-7 Days